Neulasta

In the US, Neulasta (pegfilgrastim systemic) is a member of the drug class colony stimulating factors and is used to treat Neutropenia Associated with Chemotherapy.

US matches:

• Neulasta

UK matches:

• NEULASTA
• NEULASTA (SPC)

Ingredient matches for Neulasta

Pegfilgrastim

Pegfilgrastim is reported as an ingredient of Neulasta in the following countries:

• Australia


• Austria


• Belgium


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Iceland


• Ireland


• Italy


• Luxembourg


• Netherlands


• Norway


• Poland


• Portugal


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.